Literature DB >> 16840119

The use of benzodiazepines among injecting drug users.

S Darke1.   

Abstract

Benzodiazepine use among injecting drug users (IDUs) presents a major clinical and public health problem that may increase in importance. The current paper examines the research on the extent of benzodiazepine use among IDUs and the harmful consequences associated with such use. Numerous studies have found benzodiazepine use to be widespread among IDUs, and to be associated with greater levels of risk-taking and polydrug use, and poorer psychosocial functioning than other IDUs. The injection of benzodiazepines has also been reported, and presents problems in itself. The implications of existing research for both clinical practice and research are discussed.

Entities:  

Year:  1994        PMID: 16840119     DOI: 10.1080/09595239400185741

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  4 in total

1.  Examining racial/ethnic differences in patterns of benzodiazepine prescription and misuse.

Authors:  Benjamin Cook; Timothy Creedon; Ye Wang; Chunling Lu; Nicholas Carson; Piter Jules; Esther Lee; Margarita Alegría
Journal:  Drug Alcohol Depend       Date:  2018-03-26       Impact factor: 4.492

2.  Not just heroin: Extensive polysubstance use among US high school seniors who currently use heroin.

Authors:  Joseph J Palamar; Austin Le; Pedro Mateu-Gelabert
Journal:  Drug Alcohol Depend       Date:  2018-06-04       Impact factor: 4.492

3.  Predictors of injection drug use cessation and relapse in a prospective cohort of young injection drug users in San Francisco, CA (UFO Study).

Authors:  Jennifer L Evans; Judith A Hahn; Paula J Lum; Ellen S Stein; Kimberly Page
Journal:  Drug Alcohol Depend       Date:  2009-01-31       Impact factor: 4.492

4.  The slippery slope of flubromazolam: Experiences of a novel psychoactive benzodiazepine as discussed on a Swedish online forum.

Authors:  Martin Andersson; Anette Kjellgren
Journal:  Nordisk Alkohol Nark       Date:  2017-05-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.